| 1 | Title |
| 2 |
Principal Investigators, Co-Investigators and Supervisors where applicable -Their addresses and signatures should be included -Role of investigators/supervisors as applicable -The committee may require their curriculum vitae |
| 3 | Any collaborating institution(s) |
| 4 |
Funding agency where applicable -The committee may require their curriculum vitae |
| 5 | List of abbreviations and acronyms |
| 6 | Operational definitions |
| 7 | Table of contents |
| 8 | Structured summary (Approximately 200-300 words) |
| 9 | Introduction/background |
| 10 |
Literature review including conceptual/theoretical framework |
| 11 | Rationale/ Study justification |
| 12 |
Study questions, hypothesis where applicable |
| 13 |
Objectives/Aims: a. Broad objective(s)/overall goals b. Specific objectives c. Secondary objectives if applicable |
| 14 |
Methodology: a. Study design b. Study area description -Specific study site c. Study population -Population characteristics -Definition of cases/controls if applicable -Inclusion/exclusion criteria d. Sample size determination and formula/computer programme used (assumptions and reference) e. Sampling procedure/screening/selection of study participants f. Recruitment and consenting procedures g. Variables – dependent, independent, confounders where applicable h. Data collection procedures (qualitative and quantitative data, field data collection instruments, laboratory procedures etc) i. Materials – equipment, supplies etc j. Training procedures where applicable k. Quality assurance procedures |
| 15 | Ethical consideration-briefly explain the ethical issues that may be associated with the study and strategies to address them |
| 16 | Data management (data entry, cleaning, storage, security and quality assurance, statistical analysis plans etc.) |
| 17 | Study results dissemination plan |
| 18 | Study limitations and how to minimize them |
| 19 | Study timeline/time frame |
| 20 | Study closure plan and procedure |
| 21 |
References - Use internationally accepted format e.g. Vancouver, Harvard, American Psychological Association (APA) etc. must maintain format consistency |
| 22 |
Budget and budget justification; -Consider coverage of such areas as Personnel, Salaries and Salary disbursements, Training costs, Participants service costs, Supplies and equipment, Animal acquisition where applicable, Travel and accommodation, Transport – vehicles – repair, fuel, Operating expenses – postage, report writing etc., Consultancy if applicable, Dissemination, Miscellaneous, Contingency (%) |
| 23 |
A. Informed Consent/ Assent Explanation and Consent Form
(Click for the consent explanation template) II) Consent form to include investigators and participant statement with signature page; |
| B. Study instruments/tools | |
| C. Curriculum vitae where applicable | |
| D. Reference procedures/ brochures etc. where applicable | |
| E. Maps where applicable | |
| F. Special information e.g. educational/publicity materials | |
|
G. Any other relevant information according to the study |
|
|
More information to researchers 1. Severe Adverse Events (SAE) should be reported to the KNH-UoN ERC within 72 hours as per the approved format. (Click for the SAEs form) |
|
|
|


